Dianeal Low Calcium With Dextrose Injection, Solution
Product Images NDC 0941-0409

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Dianeal Low Calcium With Dextrose (NDC 0941-0409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vantive Us Healthcare Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula Dextrose Hydrous Usp (Image 01)

Chemical structure of Dextrose Hydrous USP (D-Glucopyranose monohydrate) showing a glucose ring with hydroxyl groups and one molecule of water (H2O) associated.*

FDA Label Image

Dianeal Representative Label 0941-0411-11 (Image 02)

Label for Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose, 6000 mL. Contains 1.5 g dextrose, sodium chloride, sodium lactate, calcium chloride, and magnesium chloride per 100 mL. Sterile, nonpyrogenic solution for intraperitoneal administration only, labeled by Baxter Healthcare Corporation, Deerfield, IL.*

FDA Label Image

Dianeal Representative Label 0941-0413-07 (Image 03)

Label for Dianeal PD-2 Peritoneal Dialysis Solution with 2.5% Dextrose, an intraperitoneal injection solution by Baxter Healthcare Corporation. Each 100 mL contains 2.5 g dextrose, 538 mg sodium chloride, 448 mg sodium lactate, 25.7 mg calcium chloride, and 5.08 mg magnesium chloride. The label notes sterile, nonpyrogenic solution, storage instructions, and cautions for use under physician direction.*

FDA Label Image

Dianeal Representative Label 0941-0415-06 (Dianeal Image 04)

Label for Dianeal PD-2 Peritoneal Dialysis Solution with 4.25% Dextrose by Vantive US Healthcare LLC. The 2000 mL injection solution contains sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and dextrose. The label notes sterility, nonpyrogenic status, and includes usage warnings, storage instructions, and a caution about potassium chloride addition under physician direction.*

FDA Label Image

Dianeal Representative Label 0941-0409-07 (Image 05)

Baxter Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose injection solution in a 5000 mL Ambu-Flex II container. The label lists active ingredients and concentrations including sodium chloride 538 mg, sodium lactate 448 mg, calcium chloride 18.3 mg, and magnesium chloride 5.08 mg per 100 mL. It is sterile, nonpyrogenic, intended for intraperitoneal administration, and made by Baxter Healthcare Corporation.*

FDA Label Image

Dianeal Representative Label 0941-0457-08 (Image 06)

Label for Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, injection solution in a 2000 mL Ambu-Flex II plastic container by Baxter. The label details the solution's composition per 100 mL, sterility, and instructions for intraperitoneal use, with a caution that potassium chloride must be added only under physician direction.*

FDA Label Image

Dianeal Representative Label 0941-0459-08 (Image 07)

Label for Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose by Baxter. It is a 2000 mL injection solution for intraperitoneal use containing 4.25 g/100 mL dextrose hydrous, along with sodium chloride, sodium lactate, calcium chloride, and magnesium chloride. The label includes warnings, storage instructions, and manufacturer information (Baxter Healthcare Corporation, Deerfield, IL).*

FDA Label Image

Dianeal Representative Label 0941-0426-52 (Image 08)

Label for Dianeal PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose by Baxter Healthcare Corporation. The label indicates a 2000 mL UltraBag container and lists active ingredients including dextrose, sodium chloride, sodium lactate, calcium chloride, and magnesium chloride with their concentrations per 100 mL. The label notes the solution's pH, osmolarity, sterility, and nonpyrogenic quality, with instructions for use and storage at room temperature.*

FDA Label Image

Dianeal Representative Label 0941-0427-52 (Image 09)

Label for Dianeal PD-2 Peritoneal Dialysis Solution with 2.5% Dextrose, an intraperitoneal injection solution. The label lists active ingredients including dextrose, sodium chloride, sodium, calcium chloride, and magnesium chloride with specific concentrations per 100 mL. It comes in a 2000 mL UltraBag container, manufactured by Baxter Healthcare Corporation in the USA. The label includes usage instructions and cautions for sterile handling and physician-directed potassium chloride addition.*

FDA Label Image

Dianeal Representative Label 0941-0429-52 (Image 10)

This packaging label is for Dianeal PD-2 Peritoneal Dialysis Solution with 4.25% Dextrose by Baxter. It is an intraperitoneal injection solution contained in a 200 mL UltraBag plastic container. The solution includes sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and dextrose at specified concentrations. The label includes usage cautions, storage instructions, and states the product is sterile, nonpyrogenic, and prescription only.*

FDA Label Image

Dianeal Representative Label 0941-0424-52 (Image 11)

The packaging label for Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose, a 2000 mL UltraBag container by Baxter Healthcare Corporation. The label details the solution's composition per 100 mL, including dextrose, sodium chloride, sodium lactate, calcium chloride, and magnesium chloride concentrations, along with osmolarity and pH information. It also includes storage instructions, caution statements, and directions indicating it is for intraperitoneal administration only under physician supervision.*

FDA Label Image

Dianeal Representative Label 0941-0430-52 (Image 12)

Label of Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose by Baxter. The solution contains sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and dextrose in specified concentrations. It is sterile and non-pyrogenic, intended for intraperitoneal administration only, and supplied in an UltraBag container of 2000 mL volume.*

FDA Label Image

Dianeal Representative Label 0941-0433-52 (Image 13)

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose is a 2000 mL intraperitoneal injection solution labeled for Baxter and produced by Baxter Healthcare Corporation. The label details active ingredients including sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and dextrose with specified concentrations per 100 mL. The product is sterile, nonpyrogenic, and packaged in an UltraBag container with instructions and warnings for use, including the requirement of potassium chloride addition only under physician direction.*

FDA Label Image

Dianeal Representative Label 0941-0484-01 (Image 14)

The label for Dianeal Low Calcium Peritoneal Dialysis Solution with 1.5% Dextrose 5000 mL injection, solution for intraperitoneal use by Baxter. It contains low calcium (2.5 mEq/L) and lists active ingredients including 1.5 g dextrose hydrous, sodium chloride, calcium chloride, magnesium chloride, and sodium lactate per 100 mL. The label includes instructions for use, storage conditions at 25°C (77°F), and cautions about sterility and administration under physician direction.*

FDA Label Image

Dianeal Representative Label 0941-0487-01 (Image 15)

The packaging label for Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, a 5000 mL intraperitoneal injection solution by Baxter. The label includes detailed ingredient concentrations, administration instructions, and cautions. It specifies potassium chloride addition only under physician direction, and storage information. Made by Baxter Healthcare Corporation.*

FDA Label Image

Dianeal Representative Label 0941-0490-01 (Dianeal Representative Label 0941 0490 01)

Label for Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 4.25% Dextrose by Vantive US Healthcare LLC. The injection solution is supplied in a 5000 mL container with approximately 135 mL excess. It contains sodium chloride, sodium lactate, calcium chloride, magnesium chloride, and dextrose. The label states sterile and nonpyrogenic, and notes potassium chloride should only be added under physician direction. The label includes usage instructions and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.